Shire Announces Holding of 81% in Jerini AG and Publication of Offe... ( BASINGSTOKE England and CAMBRIDGE...)

Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document

Date:8/13/2008

BASINGSTOKE, England and CAMBRIDGE, Massachusetts, August 13 /PRNewswire-FirstCall/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that since July 3, 2008 it has acquired 81% of the shares in Jerini AG through its wholly owned indirect subsidiary Shire Deutschland Investments GmbH (formerly Maia Elfte Vermogensverwaltungs-GmbH), which today also published an Offer Document in respect of the remaining outstanding shares in Jerini.

The intention to make the voluntary takeover offer for a cash consideration of EUR6.25 per share was announced on July 3, 2008.

The offer period will expire on 10 September 2008, 24.00 CEST and the offer can be accepted until the last day of any additional acceptance period.

A copy of the Offer Document is published on Shire's website at http://www.shire.com. Details of market purchases after the publication of the Offer Document will also appear on Shire's website.

Important Information

This press release is neither an offer to purchase nor a solicitation of an offer to sell shares in Jerini AG, nor an offer to purchase or sell any other securities. The terms and conditions of the Offer are being published in the offer document as approved by BaFin. Investors and holders of shares in Jerini AG are strongly advised to read the relevant documents regarding the takeover offer published by Shire Deutschland Investments GmbH, in particular the offer document, because they contain important information. Investors and holders of shares in Jerini AG may review these documents at the web site http://www.shire.com.

Notice to US holders of Jerini shares

In accordance with normal German market practice, and pursuant to exemptive relief granted by the SEC, the Bidder or its nominees or brokers (acting as agents) may from time to time make ce
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
2. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
3. Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office
4. Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
5. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
6. Application for Listing of Shire Limited Ordinary Shares
7. Shire Launches Nationwide Adult ADHD Mobile Awareness Tour
8. Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
9. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
10. New Shire Holding Company Proposal
11. Shire to Introduce a New UK Listed Holding Company

Post Your Comments:

Shire Announces Holding of 81% in Jerini AG and Publication of Offe...( BASINGSTOKE England and CAMBRIDGE...)